716-99-4Relevant academic research and scientific papers
CRBN LIGANDS AND USES THEREOF
-
Paragraph 00388; 00389, (2019/08/20)
The present invention provides compounds, compositions thereof, and methods of using the same for the inhibition of CRBN, and the treatment of CRBN-mediated disorders.
DIHYDROURACIL COMPOUNDS AS ANTI-ICTOGENIC OR ANTI-EPILEPTOGENIC AGENTS
-
Page 33, (2010/11/30)
Methods and compounds useful for the inhibition of convulsive disorders, including epilepsy, are disclosed. The methods and compounds of the invention inhibit or prevent or treat ictogenesis, epileptogenesis, or epileptogenesis-associated conditions. Methods for preparing the compounds of the invention are also described. Particularly preferred compounds of the invention include Formula 1 as described herein.
Conversion of 1-benzyl-4-aminotetrahydropyridine-3-carboxylic acid methyl ester to antithrombotic pyrido[4,3-d]pyrimidine-2,4-diones and to (2-oxotetrahydropyrimidin-4-ylidene)acetic acid methyl esters
Furrer,Fehlhaber,Wagner
, p. 1569 - 1575 (2007/10/02)
6-Benzyl-3-methyl-5,6,7,8-tetrahydro-1H-pyrido[4,3-d]pyrimidine-2,4-di one 2, a representative of new antithrombotic compounds with favourable cerebral and peripheral effects has been synthesized from enamine 1 in good yield by two methods. The thermal fu
